Corrigendum | Open Access
Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
Received23 Dec 2018
Accepted03 Jan 2019
Published27 Mar 2019
References
Q. Zhang, H. Zhang, J. Ding et al., “Combination therapy with EpCAM-CAR-NK-92 cells and regorafenib against human colorectal cancer models,” Journal of Immunology Research, vol. 2018, Article ID 4263520, 11 pages, 2018.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2019 Qing Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.